A detailed history of Optiver Holding B.V. transactions in Genfit S.A. stock. As of the latest transaction made, Optiver Holding B.V. holds 2,243 shares of GNFT stock, worth $12,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,243
Previous 963 132.92%
Holding current value
$12,358
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.41 - $5.92 $4,364 - $7,577
1,280 Added 132.92%
2,243 $8,000
Q1 2024

May 09, 2024

SELL
$3.34 - $4.04 $271,862 - $328,839
-81,396 Reduced 98.83%
963 $3,000
Q4 2023

Feb 13, 2024

BUY
$2.97 - $3.94 $234,104 - $310,562
78,823 Added 2229.16%
82,359 $317,000
Q3 2023

Nov 13, 2023

SELL
$3.15 - $4.12 $923,189 - $1.21 Million
-293,076 Reduced 98.81%
3,536 $11,000
Q2 2023

Aug 10, 2023

BUY
$3.54 - $4.68 $955,003 - $1.26 Million
269,775 Added 1005.24%
296,612 $1.05 Million
Q1 2023

May 11, 2023

BUY
$3.93 - $4.69 $12,414 - $14,815
3,159 Added 13.34%
26,837 $110,000
Q4 2022

Feb 10, 2023

BUY
$3.53 - $4.39 $20,985 - $26,098
5,945 Added 33.53%
23,678 $103,000
Q3 2022

Nov 14, 2022

SELL
$3.26 - $4.86 $66,908 - $99,746
-20,524 Reduced 53.65%
17,733 $65,000
Q2 2022

Aug 10, 2022

SELL
$3.09 - $4.25 $7,527 - $10,353
-2,436 Reduced 5.99%
38,257 $123,000
Q1 2022

May 16, 2022

BUY
$3.14 - $5.04 $117,005 - $187,805
37,263 Added 1086.38%
40,693 $163,000
Q4 2021

Feb 14, 2022

BUY
$3.01 - $5.65 $4,828 - $9,062
1,604 Added 87.84%
3,430 $17,000
Q3 2021

Nov 15, 2021

BUY
$3.58 - $4.14 $6,537 - $7,559
1,826 New
1,826 $7,000
Q2 2021

Aug 16, 2021

SELL
$3.8 - $4.63 $155,473 - $189,431
-40,914 Closed
0 $0
Q1 2021

May 20, 2021

SELL
$4.53 - $6.06 $814,919 - $1.09 Million
-179,894 Reduced 81.47%
40,914 $189,000
Q1 2021

May 14, 2021

BUY
$4.53 - $6.06 $1 Million - $1.34 Million
220,808 New
220,808 $1.02 Million

Others Institutions Holding GNFT

About Genfit S.A.


  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $274M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.